Today, Morris & Dickson filed an appeal on the DEA’s attempt to revoke our registration to the U.S. Court of Appeals for the Fifth Circuit. The company has also asked the Court to stay DEA’s Order to prevent it from taking effect for an...
News & Insights
The M&D Buzz
Get a glimpse of the news, events, accolades, and insights that Morris & Dickson brings to the pharmaceutical industry
Update on Morris & Dickson’s Ongoing Discussion with DEA: Business continues as usual; DEA license remains active
May 26, 2023 | News
Morris & Dickson is grateful to the DEA Administrator for delaying the effective date of the Order to allow time to settle these old issues, which has been our goal since this started years ago. In the ensuing time, the company has voluntarily invested millions to...
Morris & Dickson statement in response to a news story published this morning that says the DEA may attempt to revoke the company’s registration
May 24, 2023 | News
Morris & Dickson takes seriously its commitment to ensure strict compliance with all DEA regulations. We strongly believe any attempt to revoke our registration would be unwarranted and unjustified. Most importantly, any decision the DEA makes will not disrupt our...
M&D Clinical Corner: Community Pharmacist’s Guide to Pharmacy-administered Injectables.
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of Pharmacy-Administered...
Milken Institute Highlights M&D in Recent Supply Chain Report
Morris & Dickson, the nation’s largest, independently owned, full-line pharmaceutical distributor based in Shreveport, Louisiana, was recently highlighted in a publication by the Milken Institute Center for Public Health. The report, “Envisioning...
M&D Clinical Corner: Overview of Biosimilar Drugs
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of biosimilar drugs...
Driverless Forklifts Are Revolutionizing Warehousing and Logistics at M&D
Meet Morris & Dickson’s newest distribution center employees, Wall-E, Johnny 5, R2D2, and M&D Rover 1, the industry’s most versatile self-driving, autonomous forklifts from Vecna Roboticsä. M&D’s distribution center...
M&D Clinical Corner: Guide to Medicare Changes for 2023 and Beyond
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of recent changes to...
M&D Clinical Corner: OTC Hearing Aids
Feb 9, 2023 | Insights
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). This month’s Clinical Corner will provide an overview of OTC hearing aids that...
Layne Martin named M&D Head of Specialty Sourcing
Jan 9, 2023 | News
Morris & Dickson, the nation’s largest independent full-line pharmaceutical distributor, is pleased to announce the hiring of Layne Martin as Head of Specialty Sourcing. Layne brings more than 20 years of experience in the healthcare distribution...
M&D Clinical Corner: National Influenza Vaccination Week
The Clinical Corner is a monthly feature that highlights a variety of important pharmacist topics that is written by Morris & Dickson’s staff pharmacist, Paula Belle (RPh). What’s New For 2022 National Influenza Vaccination Week (NIVW) is being...
Braden Hunter named M&D Chief Financial Officer
Nov 9, 2022 | News
Morris & Dickson, the nation’s largest independent full-line pharmaceutical distributor, has announced the hiring of Braden Hunter as Chief Financial Officer. Braden brings 20 years of finance leadership experience in revenue, expense, systems and strategy...









